BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

Elevating Alzheimer's Detection: Aptamer Group's CSO Dr. David Bunka Discusses the Impact of Optimer Binders

In a compelling conversation with BioPharma APAC, Dr. David Bunka, the Chief Scientific Officer (CSO) of Aptamer Group, unveils an ambitious endeav...

March 01, 2024 | Interview

John Graham, Zuellig Pharma Group CEO, Explores Strategic Partnership with Substipharm Biologics to Transform Healthcare in Asia

In an insightful interview with BioPharma APAC, John Graham, Group CEO of Zuellig Pharma, shares details about the strategic partnership with Substipharm B...

February 05, 2024 | Interaction

AbbVie Invests $223M to Expand Biologics Manufacturing in Singapore

US$223 million expansion will add biologics capacity to AbbVie manufacturing network Singapore manufacturing site to grow to more than 500 emp...

January 26, 2024 | News

BostonGene and Prisma Health Collaborate to Predict Immunotherapy Efficacy in Rare Cancers

BostonGene, a leading provider of AI-based molecular and immune profiling solutions provider, today announces a collaboration with Prisma Health aimed at a...

January 19, 2024 | News

Boehringer Ingelheim Invests EUR 120 Million in Greek Plant Expansion for Enhanced Medication Manufacturing and Job Creation

Main disease areas include cardio-renal-metabolic (CRM) diseases, mental health, pulmonary fibrosis, systemic sclerosis, and chronic liver disease, some of...

January 12, 2024 | News

2024 Biopharma Outlook: 24 Trends, Innovations, and FDA's Critical Role

As we step into 2024, the biopharmaceutical industry is poised for an era of unprecedented innovation and transformative breakthroughs. From cutting-edge t...

January 01, 2024 | News

Biotech and Biopharma Industry Trends: What to Watch for in 2024

In a year-round up preview, Dr. Senthil Sockalingam, Head of IQVIA Biotech in Japan-Asia Pacific and Chief Medical Officer of IQVIA Asia Pacific, offers a ...

December 18, 2023 | Opinion | By Dr Senthil Sockalingam, Head, IQVIA Biotech in Japan-Asia Pacific; Chief Medical Officer, IQVIA Asia Pacific

IQVIA Experts Share Perspectives on Challenges, Opportunities, and the Transformative Role of DCTs in Asia Pacific

In a dynamically evolving landscape of clinical research, the Asia Pacific (APAC) region has emerged as a key player in adopting Decentralized Clinical Tri...

December 13, 2023 | News

Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis

Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies Virtually screen...

December 06, 2023 | News

Hong Chow discusses Merck's ambitious €25 billion sales goal, sustainability initiatives, innovation priorities, and fostering a high-impact culture in the Asia-Pacific region

In an exclusive interview by BioPharma APAC , Hong Chow, Executive Vice President and Head of China & International for Merck's Healthcare business, pr...

November 14, 2023 | News

Hilleman Laboratories Officially Opens US$20 Million Facility in Singapore to Bolster Resilience in Vaccine Manufacturing

Hilleman Laboratories, an organisation with a mission to develop affordable vaccines and biologics against infectious diseases with unmet medical need, off...

November 09, 2023 | News